I N T E L L I G E N T T E C H

global standards such as ISO quality assurance standards among others.

GlobalLogic, a Hitachi group company specialising in digital engineering, uses this software to develop AI-powered digital health solutions that enable more efficient workflows, real-time clinical decisions based on data and more accurate remote care in underserved regions. The company develops tailormade and patient-centric autonomous clinical software with AI technologies and inclusive design to expand access to digital health systems.

SaMD is a standalone clinical technology that does not rely on specific hardware. In recent years, it has ceased to be a digital add-on to become a useful strategic tool in diagnosis, treatment and monitoring in hospitals and connected health systems.

Likewise, this technology represents the entry into new business models in the sector because it accelerates access and scales intelligent care at a speed that traditional systems would never have reached.

According to GlobalLogic, there are five forces that are redefining the development of these types of solutions and they constitute concrete opportunities to modernise health systems:

1. The rise of adaptive AI and Machine Learning 2. The evolution of the clinical workflow, ranging from remote monitoring to diagnosis and decision support 3. The growth of platform-based digital health ecosystems 4. The demand for personalised attention 5. The definition of regulatory frameworks

Another key axis in this innovation scenario is the governance of AI. Through its VelocityAI solution, the company helps ensure traceability, auditability and bias detection from the design stage in compliance with

“ With BYOD( Bring Your Own Device) platforms and cloud infrastructure, GlobalLogic’ s SaMD healthcare solutions enable healthcare to be brought to underserved regions, reducing barriers to access. Its design also prioritises usability, inclusion and continuous improvement all based on the real behaviour of patients and clinicians,” said Juan Navarro, Vice President & Head in Latin America, GlobalLogic.

Impact cases

In collaboration with leading medical technology companies, GlobalLogic has developed applications based on SaMD that optimise patient care, including:

• Portable app that collects and adjusts biometric data for monitoring

• Mobile controller for insulin pumps, key in diabetes control

• Web and mobile solution designed for cancer patients

• Smartwatch for biometric monitoring

“ These types of medical technologies are designed with two premises: offering solutions focused on patients and their needs and expanding access in underserved areas, two areas that the World Bank considers priorities in digital health. For GlobalLogic, automation in MedTech is not just about gaining efficiency but about facilitating faster and safer innovation that can save lives,” said Navarro. �

30 www. intelligenthealth. tech